针对阿迪波金:一种有前途的治疗策略
Iqraa Shaikh1, Lokesh Kumar Bhatt2
1Department of Pharmacology, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Vile Parle (W), Mumbai, India.
Neurochemical research
|July 26, 2024
概括
耐火性影响全球数百万人. 本综述探讨了阿迪波金类药物,如莱普和阿迪波涅丁,作为管理难以治疗的的潜在治疗标,通过检查它们在神经炎症和氧化应激中的作用.
科学领域:
- 神经科学是一个神经科学.
- 内分泌学 在内分泌学.
- 病理学 病理学 病理学
背景情况:
- 影响全球6500万,导致显著的神经行为,认知和心理缺陷.
- 大约30%的病例对传统治疗不耐药,需要新的治疗策略.
- 阿迪波金是来自白色脂肪组织的,调节新陈代谢,在中枢神经系统 (CNS) 中具有多方面的作用.
研究的目的:
- 审查特定阿迪波金在病发病的潜在作用.
- 突出阿迪波金作为耐火性的潜在治疗标.
主要方法:
- 文献综述侧重于阿迪波金及其在神经疾病中的参与.
- 在中枢神经系统生理学和病理学中分析了勒素,阿迪波涅克丁,阿佩林,瓦斯,维斯法丁和奇梅林在中枢神经系统中的作用.
- 检查adipokines,氧化应激和中神经炎症之间的联系.
主要成果:
- 阿迪波金与氧化应激和神经炎症有关,这是大脑退化的关键因素.
- 特定的阿迪波金,包括勒和阿迪波内克丁,在病原发生过程中显示出潜在的相关性.
- 阿迪波金的多面性中枢神经系统功能表明它们与神经系统疾病有关.
结论:
- 阿迪波基因代表了理解,特别是耐火形式的有希望的领域.
- 向阿迪波金通路可能为管理提供新的治疗途径.
- 对阿迪波金在神经炎症和氧化应激中的作用进行进一步的研究对于治疗是有必要的.
相关概念视频
Antiepileptic Drugs: Glutamate Antagonists
305
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
305
Arteries of the Lower Limbs
182
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
182
Antiepileptic Drugs: GABAergic Pathway Potentiators
363
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
363
Antiepileptic Drugs: Calcium Channel Blockers
353
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
353
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
279
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
279
Antiepileptic Drugs: Sodium Channel Blockers
475
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
475


